Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Wins $1.66M in FY 05 from NIAID to Map SNPs of Plague Bacterium and Relative

NEW YORK, April 4 (GenomeWeb News) - Perlegen Sciences has won a two-year biodefense partnership grant from the National Institute of Allergy and Infectious Diseases to genotype the plague bacterium and a related species, the company said today.

 

In collaboration with scientists at Lawrence Berkeley National Laboratory, Perlegen will use its oligo array technology to genotype the genomes of approximately 150 strains of Yersinia pestis, which causes the plague, and Yersinia pseudotuberculosis, a closely related bacterium.

 

The aim is to discover a genome-wide set of SNPs that will help to distinguish different strains and understand their biology. Perlegen plans to make the SNPs publicly available through dbSNP and othr websites.

 

The amount of the grant was not immediately available from Perlegen, but NIH databases list a two-year grant to Perlegen in 2005 entitled "Signature SNPs to Distinguish Yersinia Pestis Strains" with an award of $1.66 million in fiscal year 2005.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.